{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:48:33Z","timestamp":1792068513617,"version":"4.4.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82471388"],"award-info":[{"award-number":["82471388"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["8250162"],"award-info":[{"award-number":["8250162"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82403900"],"award-info":[{"award-number":["82403900"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U21A20393"],"award-info":[{"award-number":["U21A20393"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013365","name":"West China Hospital, Sichuan University","doi-asserted-by":"publisher","award":["ZYGD22003"],"award-info":[{"award-number":["ZYGD22003"]}],"id":[{"id":"10.13039\/501100013365","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013365","name":"West China Hospital, Sichuan University","doi-asserted-by":"publisher","award":["ZYGD23032"],"award-info":[{"award-number":["ZYGD23032"]}],"id":[{"id":"10.13039\/501100013365","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Provincial Science and Technology Support Program","doi-asserted-by":"publisher","award":["2024NSFSC1885"],"award-info":[{"award-number":["2024NSFSC1885"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC2503800"],"award-info":[{"award-number":["2022YFC2503800"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2024M752240"],"award-info":[{"award-number":["2024M752240"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2024M752236"],"award-info":[{"award-number":["2024M752236"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.clineuro.2026.109604","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:11:52Z","timestamp":1785856312000},"page":"109604","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Different oral prednisone tapering regimens for the treatment of anti-LGI1 encephalitis: A multicenter cohort study"],"prefix":"10.1016","volume":"271","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3683-4934","authenticated-orcid":false,"given":"Linjun","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaowei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4512-4296","authenticated-orcid":false,"given":"Kundian","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9383-8539","authenticated-orcid":false,"given":"Xue","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueying","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8334-1406","authenticated-orcid":false,"given":"Xiaolin","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7411-8269","authenticated-orcid":false,"given":"Jinmei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7101-4125","authenticated-orcid":false,"given":"Dong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.clineuro.2026.109604_bib1","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study","volume":"12","author":"Titulaer","year":"2013","journal-title":"Lancet Neurol."},{"issue":"5","key":"10.1016\/j.clineuro.2026.109604_bib2","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nrneurol.2017.43","article-title":"The value of LGI1, Caspr2 and voltage-gated potassium channel antibodies in encephalitis","volume":"13","author":"van Sonderen","year":"2017","journal-title":"Nat. Rev. Neurol."},{"issue":"8","key":"10.1016\/j.clineuro.2026.109604_bib3","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S1474-4422(10)70137-X","article-title":"Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series","volume":"9","author":"Lai","year":"2010","journal-title":"Lancet Neurol."},{"issue":"9","key":"10.1016\/j.clineuro.2026.109604_bib4","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1093\/brain\/awq213","article-title":"Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan\u2019s syndrome and acquired neuromyotonia","volume":"133","author":"Irani","year":"2010","journal-title":"Brain"},{"issue":"8","key":"10.1016\/j.clineuro.2026.109604_bib5","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1093\/brain\/awy109","article-title":"Distinct HLA associations of LGI1 and CASPR2-antibody diseases","volume":"141","author":"Binks","year":"2018","journal-title":"Brain"},{"issue":"8","key":"10.1016\/j.clineuro.2026.109604_bib6","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1212\/WNL.0000000000003009","article-title":"Anti-LGI1-associated cognitive impairment: Presentation and long-term outcome","volume":"87","author":"Ari\u00f1o","year":"2016","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.clineuro.2026.109604_bib7","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1111\/epi.18107","article-title":"Efficacy and safety of different oral prednisone tapering courses in adult anti-NMDAR encephalitis: A multicenter prospective cohort study","volume":"65","author":"Cai","year":"2024","journal-title":"Epilepsia"},{"issue":"12","key":"10.1016\/j.clineuro.2026.109604_bib8","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","article-title":"Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.clineuro.2026.109604_bib9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/ana.21756","article-title":"Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents","volume":"66","author":"Florance","year":"2009","journal-title":"Ann. Neurol."},{"issue":"10","key":"10.1016\/j.clineuro.2026.109604_bib10","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1212\/WNL.0b013e31822cfc6b","article-title":"Analysis of relapses in anti-NMDAR encephalitis","volume":"77","author":"Gabilondo","year":"2011","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.clineuro.2026.109604_bib11","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000958","article-title":"Long-term Functional Outcomes and Relapse of Anti-NMDA Receptor Encephalitis: A Cohort Study in Western China","volume":"8","author":"Gong","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.clineuro.2026.109604_bib12","doi-asserted-by":"crossref","DOI":"10.1177\/17562864211073203","article-title":"Clinical characteristics, long-term functional outcomes and relapse of anti-LGI1\/Caspr2 encephalitis: a prospective cohort study in Western China","volume":"15","author":"Guo","year":"2022","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.clineuro.2026.109604_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.621599","article-title":"Neuronal Surface Antibody-Medicated Autoimmune Encephalitis (Limbic Encephalitis) in China: A Multiple-Center, Retrospective Study","volume":"12","author":"Shan","year":"2021","journal-title":"Front. Immunol."},{"issue":"22","key":"10.1016\/j.clineuro.2026.109604_bib14","doi-asserted-by":"crossref","first-page":"e2300","DOI":"10.1212\/WNL.0000000000207746","article-title":"Survival Analysis of Immunotherapy Effects on Relapse Rate in Pediatric and Adult Autoimmune Encephalitis","volume":"101","author":"Yang","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2026.109604_bib15","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jns.2018.05.020","article-title":"Distinction between anti-VGKC-complex seropositive patients with and without anti-LGI1\/CASPR2 antibodies","volume":"391","author":"Yeo","year":"2018","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.clineuro.2026.109604_bib16","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.bbi.2024.05.034","article-title":"Antibody-secreting cells as a source of NR1-IgGs in N-methyl-D-aspartate receptor-antibody encephalitis","volume":"120","author":"Qing Li","year":"2024","journal-title":"Brain Behav. Immun."},{"issue":"3","key":"10.1016\/j.clineuro.2026.109604_bib17","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200221","article-title":"Genome-Wide Association Study Identifies IFIH1 and HLA-DQB1*05:02 Loci Associated With Anti-NMDAR Encephalitis","volume":"11","author":"Liu","year":"2024","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"4","key":"10.1016\/j.clineuro.2026.109604_bib18","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol."},{"issue":"6","key":"10.1016\/j.clineuro.2026.109604_bib19","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200148","article-title":"Mimics of Autoimmune Encephalitis: Validation of the 2016 Clinical Autoimmune Encephalitis Criteria","volume":"10","author":"Van Steenhoven","year":"2023","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"3","key":"10.1016\/j.clineuro.2026.109604_bib20","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/ana.25421","article-title":"Development of the clinical assessment scale in autoimmune encephalitis","volume":"85","author":"Lim","year":"2019","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.clineuro.2026.109604_bib21","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1136\/jnnp-2022-329195","article-title":"Epileptic phenotypes in autoimmune encephalitis: from acute symptomatic seizures to autoimmune-associated epilepsy","volume":"93","author":"Matricardi","year":"2022","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"7","key":"10.1016\/j.clineuro.2026.109604_bib22","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1111\/epi.17245","article-title":"Long-term seizure outcomes in patients with autoimmune encephalitis: A prospective observational registry study update","volume":"63","author":"Liu","year":"2022","journal-title":"Epilepsia"},{"key":"10.1016\/j.clineuro.2026.109604_bib23","article-title":"Long-term efficacy and safety of different corticosteroid courses plus mycophenolate mofetil for autoimmune encephalitis with neuronal surface antibodies without tumor","volume":"14","author":"Li","year":"2023","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.clineuro.2026.109604_bib24","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1111\/ene.15214","article-title":"Efficacy and tolerability of intravenous immunoglobulin versus intravenous methylprednisolone treatment in anti-N-methyl-d-aspartate receptor encephalitis","volume":"29","author":"Gong","year":"2022","journal-title":"Eur. J. Neurol."},{"issue":"10","key":"10.1016\/j.clineuro.2026.109604_bib25","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S1474-4422(22)00299-X","article-title":"Clinical characterisation of patients in the post-acute stage of anti-NMDA receptor encephalitis: a prospective cohort study and comparison with patients with schizophrenia spectrum disorders","volume":"21","author":"Guasp","year":"2022","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.clineuro.2026.109604_bib26","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE v5.0). http:\/\/evs.nci.nih.gov\/ftp1\/CTCAE\/CTCAE_5.0\/. (2017)."},{"issue":"3","key":"10.1016\/j.clineuro.2026.109604_bib27","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1600-0609.2009.01265.x","article-title":"Corticosteroid side-effects and risk for bleeding in immune thrombocytopenic purpura: patient and hematologist perspectives","volume":"83","author":"Guidry","year":"2009","journal-title":"Eur. J. Haematol."},{"issue":"9997","key":"10.1016\/j.clineuro.2026.109604_bib28","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/S0140-6736(15)61137-0","article-title":"Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trial","volume":"386","author":"Le Page","year":"2015","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.clineuro.2026.109604_bib29","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies","volume":"46","author":"Austin","year":"2011","journal-title":"Multivar. Behav. Res."},{"key":"10.1016\/j.clineuro.2026.109604_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2021.691599","article-title":"Immunotherapies for Anti-N-M-methyl-D-aspartate Receptor Encephalitis: Multicenter Retrospective Pediatric Cohort Study in China","volume":"9","author":"Guang","year":"2021","journal-title":"Front. Pediatr."},{"issue":"1","key":"10.1016\/j.clineuro.2026.109604_bib31","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1528-1167.2010.02756.x","article-title":"Human limbic encephalitis serum enhances hippocampal mossy fiber-CA3 pyramidal cell synaptic transmission","volume":"52","author":"Lalic","year":"2011","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.clineuro.2026.109604_bib32","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/jnnp-2017-315720","article-title":"LGI1, CASPR2 and related antibodies: a molecular evolution of the phenotypes","volume":"89","author":"Binks","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"Pt 10","key":"10.1016\/j.clineuro.2026.109604_bib33","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1093\/brain\/awt212","article-title":"Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype","volume":"136","author":"Irani","year":"2013","journal-title":"Brain"},{"issue":"22","key":"10.1016\/j.clineuro.2026.109604_bib34","doi-asserted-by":"crossref","first-page":"e2300","DOI":"10.1212\/WNL.0000000000207746","article-title":"Survival Analysis of Immunotherapy Effects on Relapse Rate in Pediatric and Adult Autoimmune Encephalitis","volume":"101","author":"Yang","year":"2023","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.clineuro.2026.109604_bib35","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001088","article-title":"Rituximab Treatment and Long-term Outcome of Patients With Autoimmune Encephalitis: Real-world Evidence From the GENERATE Registry","volume":"8","author":"Thaler","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"5","key":"10.1016\/j.clineuro.2026.109604_bib36","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/ane.13291","article-title":"Efficacy and safety of rituximab in autoimmune encephalitis: A meta-analysis","volume":"142","author":"Nepal","year":"2020","journal-title":"Acta Neurol. Scand."},{"issue":"3","key":"10.1016\/j.clineuro.2026.109604_bib37","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1136\/jnnp-2021-327302","article-title":"LGI1 antibody encephalitis: acute treatment comparisons and outcome","volume":"93","author":"Rodriguez","year":"2022","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"3","key":"10.1016\/j.clineuro.2026.109604_bib38","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200115","article-title":"Prolonged Corticosteroids Without Maintenance Immunotherapy for Treatment of Anti-LGI1 Encephalitis: Analysis of Outcomes and Relapse Rate","volume":"10","author":"Alkabie","year":"2023","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"10","key":"10.1016\/j.clineuro.2026.109604_bib39","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.1793","article-title":"Anti-LGI1, anti-GABABR, and Anti-CASPR2 encephalitides in Asia: A systematic review","volume":"10","author":"Ghimire","year":"2020","journal-title":"Brain Behav."},{"issue":"1","key":"10.1016\/j.clineuro.2026.109604_bib40","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/ana.24979","article-title":"Expanded phenotypes and outcomes among 256 LGI1\/CASPR2-IgG-positive patients","volume":"82","author":"Gadoth","year":"2017","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.clineuro.2026.109604_bib41","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/art.21984","article-title":"Population-based assessment of adverse events associated with long-term glucocorticoid use","volume":"55","author":"Curtis","year":"2006","journal-title":"Arthritis Rheum."},{"issue":"7","key":"10.1016\/j.clineuro.2026.109604_bib42","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/j.1468-1331.2008.02146.x","article-title":"Oral prednisone taper following intravenous steroids fails to improve disability or recovery from relapses in multiple sclerosis","volume":"15","author":"Perumal","year":"2008","journal-title":"Eur. J. Neurol."},{"issue":"4","key":"10.1016\/j.clineuro.2026.109604_bib43","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/acn3.70006","article-title":"Capturing what matters: Patient-reported LGI1-ANTibody encephalitis outcome RatiNg scale (LANTERN)","volume":"12","author":"Kelly","year":"2025","journal-title":"Ann. Clin. Transl. Neurol."}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846726002969?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846726002969?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:03:10Z","timestamp":1792065790000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846726002969"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":43,"alternative-id":["S0303846726002969"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2026.109604","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Different oral prednisone tapering regimens for the treatment of anti-LGI1 encephalitis: A multicenter cohort study","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2026.109604","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"109604"}}